{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:46:07Z","timestamp":1770896767116,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T00:00:00Z","timestamp":1146441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":6058,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1111\/j.1600-6143.2006.01295.x","type":"journal-article","created":{"date-parts":[[2006,3,20]],"date-time":"2006-03-20T10:47:18Z","timestamp":1142851638000},"page":"976-985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"P1","title":["EBV+ B Lymphoma Cell Lines from Patients with Post-Transplant Lymphoproliferative Disease Are Resistant to TRAIL-Induced Apoptosis"],"prefix":"10.1016","volume":"6","author":[{"given":"A.L.","family":"Snow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vaysberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Krams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.M.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2006.01295.x_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s002810050038","article-title":"Post-transplantation lymphoproliferative disease","volume":"20","author":"Klein","year":"1998","journal-title":"Introduction. Springer Semin Immunopathol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib2","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1097\/00007890-199911270-00015","article-title":"Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS\/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting","volume":"68","author":"Paya","year":"1999","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428190400002202","article-title":"Adoptive immunotherapy for EBV-associated malignancies","volume":"46","author":"Gottschalk","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.coph.2004.02.006","article-title":"Targeting death receptors in cancer with Apo2L\/TRAIL","volume":"4","author":"Kelley","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1006\/cyto.1999.0489","article-title":"Regulation of APO-2 ligand\/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity","volume":"11","author":"Johnsen","year":"1999","journal-title":"Cytokine"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib7","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.189.9.1451","article-title":"Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs","volume":"189","author":"Kayagaki","year":"1999","journal-title":"J Exp Med"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.4049\/jimmunol.168.3.1356","article-title":"Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice","volume":"168","author":"Cretney","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature03337","article-title":"CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death","volume":"434","author":"Janssen","year":"2005","journal-title":"Nature"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1084\/jem.20011171","article-title":"Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development","volume":"195","author":"Takeda","year":"2002","journal-title":"J Exp Med"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrc821","article-title":"Targeting death and decoy receptors of the tumour-necrosis factor superfamily","volume":"2","author":"Ashkenazi","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib12","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.4049\/jimmunol.158.9.4045","article-title":"Involvement of IL-10 in the autonomous growth of EBV-transformed B-cell lines","volume":"158","author":"Beatty","year":"1997","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib13","first-page":"4472","article-title":"Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas","volume":"63","author":"Nepomuceno","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib14","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.4049\/jimmunol.167.9.5404","article-title":"Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway","volume":"167","author":"Snow","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib15","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.4049\/jimmunol.164.8.3961","article-title":"Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells","volume":"164","author":"Zhang","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-5793(00)02042-1","article-title":"Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types","volume":"482","author":"Zhang","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib17","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","article-title":"A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling","volume":"288","author":"Chan","year":"2000","journal-title":"Science"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib18","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.288.5475.2354","article-title":"Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations","volume":"288","author":"Siegel","year":"2000","journal-title":"Science"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/MCB.22.1.207-220.2002","article-title":"Molecular ordering of the initial signaling events of CD95","volume":"22","author":"Algeciras-Schimnich","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib20","first-page":"167","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas apoptosis in Burkitt\u2019s lymphomas with loss of multiple pro-apoptotic proteins","volume":"88","author":"Hussain","year":"2003","journal-title":"Haematologica"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V98.3.795","article-title":"TRAIL\/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: Therapeutic applications","volume":"98","author":"Mitsiades","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib22","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/sj.leu.2402287","article-title":"Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D","volume":"15","author":"Olsson","year":"2001","journal-title":"Leukemia"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jcp.20392","article-title":"Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells","volume":"205","author":"Secchiero","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib24","first-page":"580","article-title":"Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells","volume":"111","author":"Clodi","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1046\/j.1365-2141.2003.04424.x","article-title":"Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt\u2019s lymphoma cell lines","volume":"122","author":"Mouzakiti","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/viro.2001.1020","article-title":"Preferential utilization of the perforin\/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells","volume":"287","author":"Khanolkar","year":"2001","journal-title":"Virology"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib27","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.160.5.2374","article-title":"Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms","volume":"160","author":"Lewinsohn","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2006.01295.x_bib28","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","article-title":"Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation","volume":"103","author":"Katano","year":"2004","journal-title":"Blood"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2006.01295.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522026752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522026752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2006.01295.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:37:46Z","timestamp":1761626266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522026752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["S1600613522026752"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01295.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EBV+ B Lymphoma Cell Lines from Patients with Post-Transplant Lymphoproliferative Disease Are Resistant to TRAIL-Induced Apoptosis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01295.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}